Contrast Enhanced Ultrasound Market Segmentation, Scope And Forecast 2025 - 2034

Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors

What Are the Key Factors Driving Contrast Enhanced Ultrasound Market Size and Growth?
The contrast enhanced ultrasound market size has grown steadily in recent years. It will grow from $2.05 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13407&type=smp

Who Are the Major Contributors to the Contrast Enhanced Ultrasound Market Growth?
The rising prevalence of chronic diseases is expected to propel the growth of the contrast-enhanced ultrasound market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and require ongoing medical management and care. Contrast-enhanced ultrasound helps provide real-time, detailed images of various chronic diseases, such as liver cirrhosis or vascular diseases associated with hypertension, contributing to more effective long-term management. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Therefore, the rising prevalence of chronic diseases will drive the growth of the contrast-enhanced ultrasound market.

How Is the Contrast Enhanced Ultrasound Market Divided by Type and Application?
The contrast enhanced ultrasoundmarket covered in this report is segmented –

1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications

Subsegments:
1) By Equipment: Ultrasound Machines, Portable Ultrasound Devices
2) By Contrast Agent: Gas-filled Contrast Agents, Microbubble Contrast Agents, Lipid-based Contrast Agents

What Are the Significant Trends in the Contrast Enhanced Ultrasound Market Across Regions?
Major companies operating in the contrast-enhanced ultrasound market are developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to improve the spatial resolution of CEUS images. The integration of advanced technologies in contrast-enhanced ultrasound enhances diagnostic capabilities, enabling healthcare professionals to obtain more detailed and accurate information about the anatomy, function, and perfusion of tissues and organs. For instance, in September 2023, Philips, a Netherlands-based company that develops and manufactures medical systems and consumer electronics products, launched Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), a super-resolution CEUS technology that uses advanced signal processing algorithms to improve the spatial resolution of CEUS images. It helps to provide high-resolution images of blood vessels and other structures to diagnose and treat a variety of diseases, including cancer, liver disease, and vascular diseases.

Who Are the Emerging Players in the Contrast Enhanced Ultrasound Market?
Major companies operating in the contrast enhanced ultrasound market report are General Electric Company, Bayer AG, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Koninklijke Philips N.V., Daiichi Sankyo Company Limited, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., J.B. Chemicals and Pharmaceuticals Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Leriva Pharma SA, Samsung Healthcare, Jodas Expoim Pvt Ltd., nanoPET Pharma GmbH, Alpinion Medical Systems, Acusphere Inc., ContextVision AB, Teratech Corporation, Solstice Pharmaceuticals B.V.

Get the full contrast enhanced ultrasound market report here:
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report

How Is Regional Performance Expected to Affect Contrast Enhanced Ultrasound Market Growth?
North America was the largest region in the contrast-enhanced ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company